Not applicableStudy completedNCT03098589What this trial is testingRevlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)Who this might be right forLymphoma Celgene 1,149
Testing effectiveness (Phase 2)Ended earlyNCT00914940What this trial is testingSelective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHDWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes Fred Hutchinson Cancer Center 41
Testing effectiveness (Phase 2)Ended earlyNCT03947255What this trial is testingRetreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell LymphomaWho this might be right forHodgkin LymphomaPeripheral T Cell LymphomaAnaplastic Large Cell Lymphoma Seagen Inc. 12
Testing effectiveness (Phase 2)Ended earlyNCT04251065What this trial is testingDaratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFHWho this might be right forRefractory T-Cell LymphomaRelapsed T-Cell Lymphoma Fondazione Italiana Linfomi - ETS 8
Testing effectiveness (Phase 2)Study completedNCT01776411What this trial is testingPhase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma PatientsWho this might be right forRecurrent or Refractory PTCL Mundipharma K.K. 49
Testing effectiveness (Phase 2)UnknownNCT06083701What this trial is testingPhase I/II Study of Linperlisib Plus Chidamide for R/R Peripheral T-cell Lymphoma: a Prospective, Multi-center StudyWho this might be right forPeripheral T Cell Lymphoma Peking Union Medical College Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT06176027What this trial is testingAzacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell LymphomasWho this might be right forRelapsed Peripheral T-Cell LymphomasRefractory Peripheral T-Cell Lymphomas Navy General Hospital, Beijing 52
Testing effectiveness (Phase 2)Study completedNCT03052933What this trial is testingCopanlisib and Gemcitabine in Relapsed/Refractory PTCLWho this might be right forMature T-Cell and NK-Cell Neoplasm Chonnam National University Hospital 28
Testing effectiveness (Phase 2)Study completedNCT00078858What this trial is testingMycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more Fred Hutchinson Cancer Center 37
Not applicableNot Yet RecruitingNCT06671717What this trial is testingPralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell LymphomaWho this might be right forRelapsed Peripheral T-Cell LymphomaRefractory Peripheral T-Cell Lymphoma Peking University People's Hospital 25
Early research (Phase 1)Looking for participantsNCT02508038What this trial is testingAlpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid TumorsWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin Lymphoma+8 more University of Wisconsin, Madison 22
Testing effectiveness (Phase 2)Study completedNCT02676778What this trial is testingStudy of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell LymphomaWho this might be right forPeripheral T-cell LymphomaCutaneous T-cell Lymphoma Eisai Co., Ltd. 45
Not applicableStudy completedNCT05137847What this trial is testingRemitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)Who this might be right forLymphoma, T-cell, PeripheralLymphoma, T-cell, Cutaneous Eisai Inc. 118
Early research (Phase 1)Study completedNCT00963274What this trial is testingBortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWho this might be right forLeukemiaLymphoma Virginia Commonwealth University 18
Early research (Phase 1)WithdrawnNCT04233697What this trial is testingCopanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell LymphomaWho this might be right forLymphoma, T-Cell Columbia University
Testing effectiveness (Phase 2)Looking for participantsNCT04390737What this trial is testingEvaluate the Safety and Clinical Activity of HH2853Who this might be right forFL LymphomaEpithelioid SarcomaPeripheral T Cell Lymphoma+1 more Haihe Biopharma Co., Ltd. 254
Testing effectiveness (Phase 2)Looking for participantsNCT06909877What this trial is testingStudy to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell LymphomaWho this might be right forRelapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL) Haihe Biopharma Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT02158975What this trial is testingOpen-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell LymphomasWho this might be right forLymphoma, T-Cell University of Michigan Rogel Cancer Center 13
Early research (Phase 1)Study completedNCT03302728What this trial is testingBrentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin LymphomaWho this might be right forLymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralHodgkin Lymphoma Peter MacCallum Cancer Centre, Australia 6
Testing effectiveness (Phase 2)UnknownNCT06468267What this trial is testingRIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.Who this might be right forPeripheral T Cell Lymphoma Xianmin Song, MD 50